Floatz logo

185 assets in Pancreatic Adenocarcinoma

Therapeutic assets addressing Pancreatic Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Anetumab Ravtansine
Pancreatic Adenocarcinoma
National Cancer Institute (NCI)P1C (39)
Anti-Egfr-Bispecific Antibody Armed Activated T-Cells
Pancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer CenterP1C (39)
asp2138
Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.P1C (39)
Autologous, Engineered T Cells Targeting Tp53 R175H
Pancreatic Adenocarcinoma
AstraZenecaP1C (39)
ba1302
Pancreatic Adenocarcinoma
Shandong Boan Biotechnology Co., LtdP1C (39)
Cadvec
Pancreatic Adenocarcinoma
Baylor College of MedicineP1C (39)
Clsp-1025
Pancreatic Adenocarcinoma
Clasp Therapeutics, Inc.P1C (39)
Cobicistat
Pancreatic Adenocarcinoma
German Cancer Research CenterP1C (39)
cs08399
Pancreatic Adenocarcinoma
Chipscreen Biosciences, Ltd.P1C (39)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.P1C (39)
Mrtx1133
Pancreatic Adenocarcinoma
Mirati Therapeutics Inc.P1C (39)
Mrtx1719
Pancreatic Adenocarcinoma
Bristol-Myers SquibbP1C (39)
Naptumomab Estafenatox
Pancreatic Adenocarcinoma
NeoTX Therapeutics Ltd.P1C (39)
Obinutuzumab
Pancreatic Adenocarcinoma
German Cancer Research CenterP1C (39)
pf-08046054
Pancreatic Adenocarcinoma
Seagen, a wholly owned subsidiary of PfizerP1C (39)
pf-08046876
Pancreatic Adenocarcinoma
PfizerP1C (39)
pf-08052666
Pancreatic Adenocarcinoma
Seagen, a wholly owned subsidiary of PfizerP1C (39)
Rmc-5127
Pancreatic Adenocarcinoma
Revolution Medicines, Inc.P1C (39)
ro7515629
Pancreatic Adenocarcinoma
Hoffmann-La RocheP1C (39)
tcr1188-abc cells
Pancreatic Adenocarcinoma
University of PennsylvaniaP1C (39)
177Lu-DOTA-ABM-5G
Pancreatic Adenocarcinoma
University of California, DavisEarly P1C (38)
[68Ga]Ga DOTA-5G
Pancreatic Adenocarcinoma
University of California, DavisEarly P1C (38)
im96 car-t cells
Pancreatic Adenocarcinoma
Beijing Immunochina Medical Science & Technology Co., Ltd.Early P1C (38)
Nogapendekin Alfa Inbakicept
Pancreatic Adenocarcinoma
ImmunityBio, Inc.P1C (38)
Personalized Neoantigen Tumor Vaccine
Pancreatic Adenocarcinoma
Ruijin HospitalEarly P1C (38)
Nisevokitug
Pancreatic Adenocarcinoma
Kimberly Perez, MDP2C (37)
Milademetan
Pancreatic Adenocarcinoma
Rain Oncology IncP1/2C (33)
FAZA
Pancreatic Adenocarcinoma
University Health Network, TorontoN/AD (30)
Mdna11
Pancreatic Adenocarcinoma
Medicenna Therapeutics, Inc.P1/2NR ()
Onvax-01
Pancreatic Adenocarcinoma
Sichuan UniversityP1NR ()
Pcx-12
Pancreatic Adenocarcinoma
Haoming (Carl) QiuP1NR ()
Rgdcradcox2F
Pancreatic Adenocarcinoma
Masonic Cancer Center, University of MinnesotaP1NR ()
Wef-001
Pancreatic Adenocarcinoma
Auricula Biosciences Inc.P1/2NR ()
Showing 151 to 185 of 185 assets
PreviousPage 4 of 4Next